Cargando…

Immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS‐CoV‐2 in adults

BACKGROUND: Asymptomatic infections may play an important role in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) Delta variant transmissions. However, the immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS‐CoV‐2 in adults remain to be defined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Rui, Mao, Qiang, Ding, Xu, Qiu, Qiwu, Wang, Pei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210569/ https://www.ncbi.nlm.nih.gov/pubmed/35759224 http://dx.doi.org/10.1002/iid3.670

Ejemplares similares

Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
por: Siedner, Mark J., et al.
Publicado: (2022)

The latent period of coronavirus disease 2019 with SARS‐CoV‐2 B.1.617.2 Delta variant of concern in the postvaccination era
por: Ma, Tao, et al.
Publicado: (2022)

Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response
por: Mahmoud, Sally A., et al.
Publicado: (2021)

Targeting SARS-CoV-2 papain-like protease in the postvaccine era
por: Ton, Anh-Tien, et al.
Publicado: (2022)

Finger stick blood test to assess postvaccination SARS‐CoV‐2 neutralizing antibody response against variants
por: Lim, Sing Mei, et al.
Publicado: (2022)

Postvaccination Multisystem Inflammatory Syndrome in Adult with No Evidence of Prior SARS-CoV-2 Infection
por: Choi, Young Kyun, et al.
Publicado: (2022)

Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients
por: Plante, Jessica A., et al.
Publicado: (2022)

Postvaccine Anti–SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients
por: Husain, Syed Ali, et al.
Publicado: (2021)

An Evaluation of Serological Tests to Determine Postvaccinal Immunity to SARS-CoV-2 by mRNA Vaccines
por: Iglesias García, Graciela, et al.
Publicado: (2022)

Evaluation of a biotin-based surrogate virus neutralization test for detecting postvaccination antibodies against SARS-CoV-2 variants in sera
por: Ahn, Min-Ju, et al.
Publicado: (2023)

Postvaccination SARS-CoV-2 Infections among Healthcare Professionals: A Real World Evidence Study
por: Perrella, Alessandro, et al.
Publicado: (2022)

Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant
por: Acharya, Charlotte B, et al.
Publicado: (2022)

Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State
por: McEwen, Abbye E, et al.
Publicado: (2021)

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
por: Boyton, Rosemary J., et al.
Publicado: (2021)

Clinical and laboratory profiles of the SARS-CoV-2 Delta variant compared with pre-Delta variants()
por: Bhakta, Shivang, et al.
Publicado: (2022)

The SARS-CoV-2 Omicron Variant Does Not Have Higher Nasal Viral Loads Compared to the Delta Variant in Symptomatic and Asymptomatic Individuals
por: Laitman, Andrew M., et al.
Publicado: (2022)

SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition
por: Terpos, Evangelos, et al.
Publicado: (2022)

Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
por: Kannan, Saathvik R., et al.
Publicado: (2021)

SG-APSIC1054: Sputnik-V postvaccination immunologic responses in nasal mucosa: A prospective cohort study in Kazakhstan
por: Kadyrova, Irina, et al.
Publicado: (2023)

Clinical characteristics and severity of beta and delta variants of SARS-CoV-2 and the effect of vaccine on delta variants
por: Peng, Yahui, et al.
Publicado: (2022)

Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents
por: Zagouri, Flora, et al.
Publicado: (2022)

TH-126. Preliminary results of an Andalucía-South of Spain multicentric registry of SARS-CoV-2 postvaccination neuromuscular pathology
por: Lafuente, Christian, et al.
Publicado: (2022)

Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study
por: Mathema, Barun, et al.
Publicado: (2021)

Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
por: Dong, Rui, et al.
Publicado: (2022)

Postvaccinal Encephalitis after ChAdOx1 nCov‐19
por: Zuhorn, Frédéric, et al.
Publicado: (2021)

Deciphering SARS-CoV-2 Virologic and Immunologic Features
por: Lebeau, Grégorie, et al.
Publicado: (2020)

Epidemiological and immunological features of obesity and SARS-CoV-2
por: Nilles, Eric J, et al.
Publicado: (2020)

Epidemiological and Immunological Features of Obesity and SARS-CoV-2
por: Nilles, Eric J., et al.
Publicado: (2021)

Epidemiology Features and Effectiveness of Vaccination and Non-Pharmaceutical Interventions of Delta and Lambda SARS-CoV-2 Variants
por: Bai, Wenqing, et al.
Publicado: (2021)

B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies
por: Zhan, Yan, et al.
Publicado: (2022)

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
por: Bager, Peter, et al.
Publicado: (2021)

Emergence of the Delta Plus variant of SARS-CoV-2 in Iran
por: Rahimi, Farid, et al.
Publicado: (2021)

SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
por: Meyerowitz, Eric A., et al.
Publicado: (2022)

Airborne transmission of the Delta variant of SARS-CoV-2 in an auditorium
por: Huang, Jianxiang, et al.
Publicado: (2022)

Postvaccine Myocarditis: A Risk Worth the Reward?
por: Raman, Betty, et al.
Publicado: (2022)

Clinical Characteristics of COVID-19 Patients' Postvaccination
por: Zhang, Xiao-Bin, et al.
Publicado: (2022)

Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis?
por: Huang, Jin-Xian, et al.
Publicado: (2022)

Postvaccine myocarditis and the use of antipyretics: Is there any relation?
por: Fatima, Maurish, et al.
Publicado: (2023)

Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2
por: Li, Gun, et al.
Publicado: (2022)

Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants
por: Lu, Jia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qp42vdj2qtt64cua8pnandgn9u